CTF in the NewsFeaturedFeatured EUScience & Research PharmaPhorum Interview: How Drug Repositioning is Accelerating Treatments for NF Patients
FeaturedNF1Patient EngagementScience & Research Summary Report from NF Patients’ Testimony to FDA about living with cutaneous neurofibromas
FeaturedGlobalNF ConferencePress ReleaseScience & ResearchTop Story EU Children’s Tumor Foundation Europe Leads Collective Effort in Accelerating Therapeutics and Innovation for Rare Diseases
Awards & GrantsScience & Research Children’s Tumor Foundation Names Rosalie Ferner, MD, 2024 Friedrich von Recklinghausen Award Winner
Collaborations & PartnershipsNF2-SWNPress ReleasePublicationsScience & ResearchTop StoryTop Story EU Brigatinib Shows Promise for NF2-SWN: A Direct Result of CTF’s Synodos Initiative